Joint Formulary & PAD

Certolizumab pegol - Rheumatoid arthritis

You are here : Home > Formulary Search > Certolizumab pegol - Rheumatoid arthritis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
ICB
NICE
SPC
Restrictions / Comments :

Documentation

NICE Technology Appraisal
NICE TA375 - Biologics in Rheumatoid Arthritis - January 2016
NICE Technology Appraisal
NICE TA415 - Certolizumab pegol for rheumatoid arthritis after TNF-alpha inhibitor -October 2016

PAD Profile

ChemicalSubstance :
Certolizumab pegol
Indication :
Rheumatoid arthritis
Group Name :
Keywords :
RA, Biologic, NICE, immunosuppressant, Cytokine modulator, TNF Alpha Inhibitor, DMARD, bDmard, Disease modulating, Rheumatology
Brand Names Include :
Cimzia
Important Information :
Severe disease only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Rheumatoid arthritis
Supporting Documents :
2

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Certolizumab pegol is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Rheumatoid arthritis.